United States · 
What does Perceptive Advisors invest in?
Perceptive Advisors invests most often at Series B and Series C (48% of the rounds on record), in sectors such as Healthcare, Biotech and Life Sciences.
Perceptive Advisors highlights
- 01
50 cheques in the last 12 months
- 02
Mostly Series B and Series C: 48% of its rounds
- 03
Sole investor in 14 rounds, median $33M
- 04
2 exits from the portfolio
What they do
investing across the capital structure in both private and public companies to fuel innovationFrom their own website
- Type
- Asset manager
- Cheque size
- $100K – $10M as they say
- Stages
- SeedSeries ASeries BGrowthPre-IPO
- Sectors
- HealthcareBiotechLife Sciences
- Based in
- New York, United States
- Cold pitches
- Not accepted
The record
Every round we can evidence, newest first206 appearances
- 2026
41 rounds
- Oct
- Sept
- Sept
- Sept
- Aug
- Jul
- Jul
- Jul
- Jul
- Jun
- Jun
- Jun
- Jun
- Jun
- Jun
- Jun
- Jun
- Jun
- May
- May
- May
- Apr
- Apr
- Apr
- Apr
- Apr
- Apr
- Apr
- Mar
- Mar
- Mar
- Mar
- Mar
- Mar
- Mar
- Mar
- Feb
- Feb
- Feb
- Feb
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration4 named
ARAlexander RakitinChief Compliance OfficeriForm ADV
JHJames Henry MannixChief Operating OfficeriForm ADV
JEJoseph Eric EdelmanChief Executive Officer and Portfolio ManageriForm ADV
PWPeter William FierroChief Financial OfficeriForm ADV
We also hold 17 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$12Bassets it managesOct 2026
Registeredinvestment adviserfull reporting to the SEC
- Legal name
- Perceptive Advisors LLC.
- SEC number
- CRD 154703
Funds on its Form ADV
20 private funds, $9.6B in gross assets · filed Aug 2024
Private equity 9Hedge 5Credit-related fund 4
- Perceptive Life Sciences Master Fund, LTDHedge400 investors$5.6B
- Perceptive Credit Opportunities Fund IV, L.P.Hedge285 investors$1.4B
- Perceptive Credit Opportunities Fund III, L.P.Hedge151 investors$1.1B
- Perceptive Credit Opportunities Fund II, L.P.Hedge123 investors$540M
- Perceptive Xontogeny Venture Fund II, L.P.Venture181 investors$508M
- PCOF Phoenix II Fund, L.P.Hedge4 investors$207M
- Perceptive Xontogeny Venture Fund, L.P.Venture134 investors$179M
- LEV LB Holdings, L.P.Private equity37 investors$98M
- PCOF EQ AIV III, L.P.Credit-related fund101 investors$7.0M
- Perceptive LS (A), LLCPrivate equity5 investors$6.8M
And 10 more on the filing.
Exits from the portfolio
Companies it backed that were later bought or listed2 in all
EUSA PharmaBought by Jazz Pharmaceuticals$650MApr 2012
EUSA PharmaBought by EUSA Pharma$23MMar 2008
An exit counts when it came after the firm's first round in the company. From historical deal records.